Skip to content

LKO -LMC

Active
Private limited companyfounded 199233 years activeNijverheidslaan 5150, 3800 Sint-Truiden, BelgiumKBO/BCE: BE 0448.579.666
Summary

LKO -LMC has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.6m and a net result of €3.9m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 25% of 779 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
#4 company by total assets in Sint-Truiden, Health and social work sector2 sites
Size
€22.1mturnover 2025
Staff
58.3 FTE
Equity
€2.6m
Profit
€3.9m
Financial health
96 Excellent Checked score 2025
Bankruptcy probability, 12 months
< 0.1%
Structure
Parent
CAB SELAS - Soc. d'excercice libéral par actions simplifiéé · 99.8%
Accounts 28 days early0 of 19 deeds read
Why 96- Equity €2.6m (23.1% of total assets)+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 1.26, cash €4.4m+ Size: turnover €22.1m, 58.3 FTE, total assets €11.1mShow the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 68% of its sector peers (NACE 86, medium-sized)
Financial strength · tick = 2024
Strong
Solvency 48+4
equity 23.1% of total assets
Liquidity 58+3
short-term debt 76.9% · cash 39.6%
Profitability 100=
return on assets 34.8%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (83 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit up to €240,000 at 30 days acceptable
Liquidity tight (current ratio 1.26 against 1.19 in 2024; short-term debt: 76.9% and cash: 39.6% of total assets), and 76.9% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, medium-sized): better than 25% on solvency, 59% on liquidity, 97% on profitability and 90% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.26, cash €4.4m
NBB · annual accounts
raises risk · Equity €2.6m (23.1% of total assets)
NBB · annual accounts
lowers risk · Size: turnover €22.1m, 58.3 FTE, total assets €11.1m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 779 sector peers (2025).
NBB · sector comparison
Position among 779 sector peers
Solvency
better than 25%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €2.6m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
28 days early
2024
16 days early
2023
13 days early
2022
7 days early
2021
24 days late
2020
8 days early
2019
14 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 19 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Equity above €2mEq €2.6m ▲50.7%
  3. Annual accounts filedfiscal year 2024 · full…

Key points

  • Positive: Among the best 5% on net resultsector median €72,207 · 773 companies €3.9m View
  • Positive: 8 profitable years in a rowprofit 2025: €3.9m 8 years View
  • Positive: Equity rose in 2025from €1.7m to €2.6m ▲ 50.7% View
  • Controlled by CAB SELAS - Soc…known shareholders 100% 99.8% View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View
  • Flemish supportawarded 2022 - 2025 €83,603 View

By topic

Financials

Fiscal year
2025
Turnover
€22.1m
Profit
€3.9m
Solvency
23.1%
Turnover▲ 10.3%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2017
Next accounts
by 31-07-2027
  1. 18-07-2024Annual accounts filed
  2. 24-07-2023Annual accounts filed
  3. 31-12-2022Equity above €1m
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
09-11-1992
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.